Aurigon (Drug Discovery) Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 100
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 1

Aurigon (Drug Discovery) General Information


Operator of a pharmaceutical research institute designed to offer preclinical services for human and veterinary pharmaceuticals. The company provides services such as early-phase product efficacy and safety evaluation to regulatory toxicology and late-stage pre-marketing testing, enabling pharmaceutical companies to develop their clinical and non-clinal drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Planegger Straße 9a
  • 81241 Munich
  • Germany
+49 089 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurigon (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 02-Mar-2015 Completed Generating Revenue
To view Aurigon (Drug Discovery)’s complete valuation and funding history, request access »

Aurigon (Drug Discovery) Executive Team (8)

Name Title Board Seat Contact Info
Gregor Mirow Chief Financial Officer & Chief Operating Officer
István Gacsályi Managing Director
Richard Graf Waldburg Managing Director
You’re viewing 3 of 8 executive team members. Get the full list »

Aurigon (Drug Discovery) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aurigon (Drug Discovery) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioM Biotech Cluster Development Accelerator/Incubator Minority 000 0000 000000 0
To view Aurigon (Drug Discovery)’s complete investors history, request access »